Which stage of liver cancer is associated with excessive sleepiness?
Drowsiness is one of the most common symptoms in liver cancer patients and can occur at any stage of the disease.
Drowsiness refers to sleep disturbances experienced by liver cancer patients, primarily manifesting as nighttime sleep disorders—patients may have insufficient sleep at night and excessive sleep during the day, or inadequate daytime sleep compared to normal individuals. Drowsiness can appear at any stage of liver cancer, but its incidence is higher among patients with advanced-stage disease.
Drowsiness in liver cancer patients can be divided into three stages. In the first stage, patients experience increased sleep but are still able to control their sleep duration. In the second stage, patients show明显 increased sleep, and although they can still exert some control over their sleep, this ability is weakened. In the third stage, patients exhibit显著ly increased sleep, with nearly complete loss of sleep control, making it almost impossible for them to regulate their sleep patterns.
Drowsiness associated with liver cancer can be improved under medical guidance through pharmacological treatment. Commonly used medications include diazepam tablets and sorafenib tablets. However, patients need to undergo regular liver function tests to ensure the effectiveness and safety of drug therapy.